Background During the Omicron variant outbreak of COVID-19 (2022–2023), Chinese
healthcare institutions combined traditional Chinese medicine (TCM) with Western medical …

This document is the revised edition of the previously issued Shanghai Expert Consensus
on Clinical Protocol for Traditional Chinese Medicine Treatment of COVID-19 among the …

Patients infected with the Omicron variant of SARS-CoV-2 mainly develop mild COVID-19,
manifesting as upper respiratory symptoms, fatigue, and fever. Shufeng Jiedu capsule …

Objective: Reyanning mixture has been demonstrated to be effective in treating infected
patients during the outbreak pandemic of SARS-CoV-2 Omicron variant of Coronavirus …

The coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019 and was …

Background Wenzhou has achieved great progress in the prevention and control of the
growing coronavirus disease 2019 (COVID-19) pandemic, and traditional Chinese medicine …

Methods This study was a prospective cohort study that observed non-critical COVID-19
inpatients. The differences will be observed in the time from admission to two consecutive …

Objective To evaluate the efficacy and safety of Huashi Baidu Granules (HSBD) in treating
patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron …

This study aimed to investigate the efficacy of Traditional Chinese Medicine (TCM) decoction
with different intervention timepoints in the treatment of coronavirus disease 2019 (COVID …

Objective From the beginning of 2020, our study team formulated a traditional Chinese
medicine (TCM) prescription named Sanhanhuashi formula (SHHS) to treat COVID-19 …